Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Schedule of Common Stock Warrant Activity (Details)

v3.20.2
Stockholders' Equity - Schedule of Common Stock Warrant Activity (Details)
 9 Months Ended
Sep. 30, 2020
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding at beginning | shares 5,532,267
Exercised | shares (625,407)
Outstanding at ending | shares 4,906,860
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Exercise Price [Roll Forward]  
Outstanding at beginning | $ / shares $ 4.00
Exercised | $ / shares 2.20
Outstanding at ending | $ / shares $ 4.23
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract]  
Outstanding at beginning | $ $ 10,470,008 [1]
Outstanding at ending | $ $ 11,091,657 [1]
[1] Intrinsic value is calculated as the estimated fair value of the Company's stock at the end of the related period less the option exercise price of in-the-money options.